AS Tallink Grupp Statistics for July 2025
In July 2025 AS Tallink Grupp transported 783,324 passengers, which is a 4.6% increase compared to July 2024. The number of cargo units decreased by 10.2% to 19,519 units and the number of passenger vehicles increased by 0.6% to 112,209 units compared to the same period a year ago.
AS Tallink Grupp passenger, cargo unit and passenger vehicle numbers for July 2025 were the following: July 2025 July 2024 Change Passengers 783,324 748,902 4.6% Finland – Sweden 214,552 212,531 1.0% Estonia – Finland 502,930 440,974 14.0% Estonia – Sweden 65,842 95,397 -31.0% Cargo Units 19,519 21,734 -10.2% Finland – Sweden 2,440 2,838 -14.0% Estonia – Finland 14,811 16,265 -8.9% Estonia – Sweden 2,268 2,631 -13.8% Passenger Vehicles 112,209 111,564 0.6% Finland – Sweden 16,843 16,065 4.8% Estonia – Finland 89,188 88,671 0.6% Estonia – Sweden 6,178 6,828 -9.5%
FINLAND – SWEDEN
The July Finland-Sweden results reflect the operations of the Helsinki-Stockholm (the cruise ferries Silja Serenade and Silja Symphony) and Turku-Stockholm (the cruise ferry Baltic Princess) routes.
ESTONIA – FINLAND
The July Estonia-Finland results reflect the operations of the shuttle vessels MyStar and Megastar and the cruise ferry Victoria I. A year ago, the cruise ferry Victoria I operated the Tallinn-Stockholm route from 31 May until 31 August 2024.
ESTONIA – SWEDEN
The July Estonia-Sweden results reflect the operations of the Tallinn-Stockholm (the cruise ferry Baltic Queen) and the Paldiski-Kapellskär (the passenger vessel Superfast IX) routes. A year ago, the Paldiski-Kapellskär route was operated by two cargo vessels – Sailor and Regal Star. Also, the Tallinn-Stockholm route was operated by two cruise ferries, Baltic Queen and Victoria I, from 31 May to 31 August 2024.
Anneli Simm
Investor Relations Manager
AS Tallink GruppSadama 5
10111 Tallinn
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Duolingo Reports 41% Revenue Growth, 46% Subscription Revenue Growth and Record Profitability in Second Quarter 2025; Raises Full-Year Guidance
PITTSBURGH, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL) announced results for the second quarter ended June 30, 2025 in a shareholder letter that is posted on its Investor Relations website at 'We exceeded our own high expectations for bookings and revenue this quarter, and did it while expanding profitability,' said Luis von Ahn, Co-Founder and CEO of Duolingo. 'Engagement remained strong, and we've seen encouraging early signals from new product initiatives like our Energy mechanic and Chess course.' 'We believe we're still early in our user growth journey. We've delivered innovation while growing profitability—through strong performance across all subscription tiers, continued investment in our core product, and new subjects that help us increase engagement. We remain focused on building for long-term engagement and growth.' Video Webcast Duolingo will host a video webcast to discuss its quarterly results today, August 6, 2025 at 5:30 p.m. ET. This live webcast and related materials will be publicly available and can be accessed at A replay will be available on the Investor Relations section of our website two hours following completion of the webcast and will remain available for a period of one year. About Duolingo Duolingo is the leading mobile learning platform globally. Its flagship app has organically become the world's most popular way to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. With technology at the core of everything it does, Duolingo has consistently invested to provide learners a fun, engaging, and effective learning experience while remaining committed to its mission to develop the best education in the world and make it universally available. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements other than statements of historical facts contained in this press release, including without limitation, statements regarding our planned investments, strategic priorities and new product initiatives, the ability of our products to drive growth, and our financial outlook are forward-looking statements. Without limiting the generality of the foregoing, you can identify forward-looking statements because they contain words such as 'may,' 'will,' 'shall,' 'should,' 'expects,' 'plans,' 'anticipates,' 'could,' 'intends,' 'target,' 'projects,' 'contemplates,' 'believes,' 'estimates,' 'predicts,' 'potential,' 'goal,' 'objective,' 'seeks,' or 'continue' or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are neither promises nor guarantees, but involve a number of known and unknown risks, uncertainties and assumptions that may cause our actual results, performance or achievements to differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: our ability to retain and grow our users and sustain their engagement with our products; competition in the online language learning industry; our limited operating history; our ability to maintain profitability; our ability to manage our growth and operate at such scale; the success of our investments; our reliance on third-party platforms to store and distribute our products and collect revenue; our reliance on third-party hosting and cloud computing providers; our ability to compete for advertisements; acceptance by educational organizations of technology-based education; changes in our business and macroeconomic conditions; our ability to access, collect, use, and otherwise process Personal Data about our users and payers, and to comply with applicable data privacy laws; our ability to successfully develop, implement and use of artificial intelligence and machine learning technologies; our ability adequately obtain, protect and maintain our intellectual property rights; and the other important factors more fully detailed under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as any such factors may be updated from time to time in our other filings with the Securities and Exchange Commission ('SEC'), accessible on the SEC's website at and the Investor Relations section of the Company's website at All forward-looking statements speak only as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, unless required by applicable law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contacts Investor Relations:Deborah Belevan, VP of Investor RelationsIR@ Press:press@
Business Upturn
3 hours ago
- Business Upturn
Freeman Quantitative Trading (FQAI) 5.0 Concludes Strategic Selection in Europe
Seattle, WA , Aug. 06, 2025 (GLOBE NEWSWIRE) — Freeman Quantitative Trading (FQAI) 5.0 has successfully concluded its European strategic selection initiative, marking a major step in the platform's regional expansion and community-based development model. The process sets the foundation for deeper adoption of FQAI 5.0's AI-powered quantitative trading tools across key European markets. Spanning several months, the selection process invited participation from multiple strategy teams competing through live strategy testing, educational content, and investor community engagement. Thousands of users across Germany, France, the Netherlands, Switzerland, and beyond joined the event, highlighting growing interest in AI-managed investment platforms. This initiative was designed not only to identify local strategic direction but also to promote inclusive investor education. Through open teaching, real-time interaction, and collaborative testing, users gained practical exposure to algorithmic investing and quantitative logic—lowering the barrier to entry for individuals new to the field. Freeman Quantitative Trading emphasized that FQAI 5.0 is more than a tool—it is a scalable ecosystem. The system combines AI modeling, big data analytics, and dynamic risk control, delivering institutional-grade capabilities through fully automated workflows. With the support of regional strategy teams selected through this initiative, the platform aims to localize deployment, enhance user experience, and tailor features to the unique needs of European investors. The strategic framework now in place will guide the implementation of educational initiatives, community-driven updates, and region-specific AI strategy modules. Upcoming releases include AI-managed trading, smart stop-loss/take-profit tools, and customizable strategy switching options—all designed to improve user control, transparency, and long-term portfolio performance. Marcus Ellington, Director of Strategic Development at Freeman Quantitative Trading, stated: 'This program reflects our vision to bridge advanced AI with inclusive financial services. Europe is a key part of our global roadmap, and we are committed to building a localized, transparent, and collaborative investing environment.' As AI continues to reshape global finance, Freeman Quantitative Trading (FQAI) 5.0 is positioned to lead the way in combining automation, risk intelligence, and investor education. The success of this strategic initiative confirms the demand for accessible, intelligent tools that empower users to navigate complex markets with confidence. About Freeman Quantitative Trading: Freeman Quantitative Trading is a leading European fintech platform specializing in AI-powered quantitative investment solutions. Its flagship system, FQAI 5.0, integrates nine core trading strategies—including trend-following, statistical arbitrage, and sentiment-driven models—into an automated, user-friendly platform. With a mission to democratize intelligent finance, Freeman combines advanced technology with investor education to make data-driven trading accessible to all. Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
3 hours ago
- Business Upturn
Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
Boston, Aug. 06, 2025 (GLOBE NEWSWIRE) — As global demand for aesthetic enhancement rises, medical aesthetic devices are transforming how patients approach cosmetic care. From laser-based treatments to minimally invasive procedures, leading companies such as AbbVie, Alma Lasers, and Johnson & Johnson to invest in next-generation technologies to meet patient expectations for precision, safety, and recovery time. According to the report, the growing adoption of non-invasive techniques, rapid advances in cosmetic laser systems, and the rise in medical tourism are redefining treatment standards. The global market is projected to grow at a CAGR of 11.3% from 2024 to 2029. As North America maintains its leadership and Europe rapidly scales access to aesthetic treatments, manufacturers must navigate strict regulatory frameworks, ensure clinical efficacy, and address affordability to realize the sector's full potential. Market Overview: Key Insights and Forecast BCC Research's latest report, Medical Aesthetic Devices: Technologies and Global Markets, offers a comprehensive assessment of the evolving aesthetics landscape. It explores innovations across laser systems, breast implants, body contouring tools, and injectables, while also examining demand trends by age group, geographic region, and treatment type. The global market for medical aesthetic devices was valued at $20.1 billion in 2023 and is projected to reach $37.9 billion by the end of 2029. The report delivers forward-looking insights based on past sales trends, device approvals, clinical trial momentum, and regional adoption patterns. It segments the market by device type, application, and end user, supported by data- intensive analysis of market size, product strategies, and regional shifts. Market Leadership in Transition The competitive landscape is evolving as companies scale energy and non-energy-based devices to support dermatological, surgical, and body contouring applications. Non-energy-based aesthetic devices—such as breast implants and dermal fillers—are expected to dominate the market by value through 2029. Companies such as Bausch Health Companies, Merz Pharma, and S.p.A. are advancing proprietary solutions aimed at scar reduction, wrinkle treatment, and facial rejuvenation. These companies are expanding regionally and leveraging partnerships for clinical validation and faster approvals (Chapter 7: Competitive Intelligence). Emerging Technologies and Investment Trends Technology is pushing the boundaries of aesthetic medicine. Robotic-assisted procedures, AI-guided skin diagnostics, and plasma-based skin therapies are expanding the range of possibilities for clinicians and patients alike. Startups such as Nova Plasma Ltd. and InMode are entering the field with breakthrough platforms targeting both safety and personalization. These shifts are driving fresh investments and accelerating product development cycles—particularly in light-based therapies and microfocused ultrasound applications (Chapter 5: Emerging Technologies and Developments). Pipeline Assessment and Applications Device manufacturers are investing heavily in next-gen solutions that blur the lines between cosmetic and therapeutic care. Procedures such as non-surgical body contouring and RF microneedling are expanding beyond traditional beauty centers and entering mainstream healthcare environments. Procedures for anti-aging, facial sculpting, and skin resurfacing are leading R&D investment, with a strong pipeline of multi-modal platforms that offer real-time feedback and adaptable energy delivery (Chapter 6: Market Segmentation Analysis). Regulatory and Access Challenges Regulatory bodies in the U.S., EU, and Asia are tightening controls around efficacy claims, clinical performance, and safety data. From FDA approvals to CE mark certifications, device manufacturers must maintain ongoing compliance for sustained market presence. Countries such as Japan, China, and Saudi Arabia are building tailored frameworks to govern the fast-evolving aesthetics space. Meanwhile, fragmented reimbursement policies and variable access in emerging economies continue to challenge equitable adoption (Chapter 4: Industry Outlook: Regulatory Framework). Strategic Outlook: The Road Ahead As the medical aesthetics field evolves, manufacturers are intensifying efforts to enhance procedural precision, minimize recovery time, and offer patient-specific outcomes. This includes innovations in ergonomic device design, non-invasive treatment delivery, and seamless clinical workflow integration (Chapter 7: Competitive Intelligence). In parallel, sustainability efforts are gaining traction across the value chain. From reduced material waste, greener energy consumption, and lifecycle-conscious device design to energy-efficient R&D practices, these priorities are increasingly being embedded into product development and procurement strategies. Firms aligning innovation with ESG values are better positioned to lead the next wave of responsible growth (Chapter 9: Sustainability in the Medical Aesthetic Device Industry; Chapter 7: Competitive Intelligence). Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $20.1 billion Market size forecast $37.9 billion Growth rate CAGR of 11.3% for the forecast period of 2024-2029 Segments covered Device Type, Application, End User, and Region Regions covered North America, Europe, Asia-Pacific and the Rest of the World (RoW) Countries covered U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia Market drivers Adoption of minimally-invasive devices. Increase in medical aesthetic procedures. Developments in cosmetic surgery using laser technology. Rise in prevalence of obesity. Rise in medical tourism. Increase in demand for breast augmentation surgeries. Additional Insights: Global demand for medical aesthetic and cosmetic surgery procedures remains strong, with the U.S., Brazil, Japan, Italy, and Mexico the top five countries for total procedures performed. In 2023, the total number of surgical and non-surgical aesthetic procedures increased by 3.4%, reaching approximately 34.9 million worldwide . Breast augmentation continues to lead as the most commonly performed cosmetic surgery, accounting for 16.0% of all surgical procedures, followed by liposuction (15.1%), eyelid surgery (12.1%), rhinoplasty (8.4%), and abdominoplasty (7.6%). Women account for nearly 85.5% of all surgical cosmetic procedures performed worldwide. Market leaders include: AbbVie Inc. Alma Lasers Bausch Health Companies Inc. Candela Corp. Cutera Inc. Cynosure Lutronic Spa Implantech Johnson & Johnson Lumenis Be Ltd. Medytox Merz Pharma Photomedex Tiger Biosciences Venus Concept Get your copy of the report directly from BCC Research. To request more information or complete your purchase, connect with us at [email protected]. About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email [email protected] or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
